PATENT CLAIM ANALYSIS

Application Number: 15750013
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "085100"]

Abstract:
The disclosure provides a new source of peripheral blood naive/memory stem cells (i.e. (T N )/T SCM /T CM ) T-cells with enhanced reconstitution potential and/or longer life spans. It discloses that this particular subset of T-cells can be mobilized by administration of at least one mobilizer in combination with at least one E-Seiectin inhibitor.

Claim (Index 2):
The method of  claim 1 , wherein the at least one mobilizer is G-CSF.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.2449
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14303385', '14006641', '14425713', '12747324', '15316792']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7250993726660635
- 35 USC 102 Novelty (BERT): 0.5695749830644583
- Combined Prediction Score: 0.7095469337059029
- Mean Citation Score: 227.991818
- Max Citation Score: 241.22922000000003
- Similarity Product: 127.20614915890934

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test